Last updated: April 11, 2023
Sponsor: Rennes University Hospital
Overall Status: Completed
Phase
N/A
Condition
Circulation Disorders
Lung Injury
Heart Attack (Myocardial Infarction)
Treatment
N/AClinical Study ID
NCT03262155
35RC16_3037_IMPECstudy
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient older than 18 years old
- Patient hospitalized in an intensive care unit
- Patient whose initial ARDS or Cardiogenic shock began less than 5 days beforeadmission
- Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS or - Patientshospitalized for ARDS or Cardiogenic shock without ECMO / ECLS
Exclusion
Exclusion Criteria:
- Opposition of patient, relative or legal representative for participation in the study
- Pregnant woman
- Pre-immunodepression
- Implementation of immunosuppressive therapy such as chemotherapy, cyclophosphamide,high-dose corticosteroids (> 0.5mg / kg / day).
Study Design
Total Participants: 18
Study Start date:
January 01, 2017
Estimated Completion Date:
January 31, 2019
Connect with a study center
CHU de Rennes
Rennes, 35033
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.